Clinical Trial Update: Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

View source ↗

Summary

Novartis is conducting a clinical trial in Russia to assess lipoprotein(a) levels in patients with atherosclerotic cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atherosclerotic Cardiovascular Disease | Status: RECRUITING